Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,020.00
Bid: 12,020.00
Ask: 12,024.00
Change: -136.00 (-1.12%)
Spread: 4.00 (0.033%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eurozone: "Sometimes you just need a bit of luck"

Tue, 24th Jan 2023 10:54

STOXX 600 down 0.4%

*

Euro zone PMI returns to growth

*

U.S. stock futures dip

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

EUROZONE: "SOMETIMES YOU JUST NEED A BIT OF LUCK" (1043 GMT)

It looks the "no recession in the euro zone" camp is getting bigger by the day. And that's quite a turnaround from what was the consensus thinking only a couple of months ago.

The latest sign the currency bloc may escape deep negative growth in 2023 came from PMI data that showed business activity made a surprise return to modest growth in January.

That could strengthen the European Central Bank's hand for another 50 basis points interest rate hike next week. But it could also reassure those who recently started pouring money back into the region battered assets.

The STOXX 600 is off to its best start to the year on data going back to 1987 and the euro has rallied 15% against the U.S. dollar from September's 20-year low.

"It's looking like 2023 could be a year of sluggish growth but not recession," said Steven Bell, economist at Columbia Threadneedle in London.

ING's Bert Colijn said whether there's a recession is now a matter of "semantics" and while "the overall sense of stagnation will likely prevail for most", mild temperatures and plentiful natural gas inventories mean more dramatic scenarios have been avoided.

"Sometimes you just need a bit of luck," Colijn wrote.

Read more here: After a long, cold year, investors are flocking back to Europe

STOXX DIPS ON HEALTHCARE DRAG (0912 GMT)

European shares slipped just below parity on Tuesday shortly after a slightly positive start, with the STOXX 600 last down around 0.1%.

The top risers are a sea of Nordic names led by Norwegian fish farmer Salmar, with shares up 6.3% following a media report of possible changes to Norway's resource rent tax. Norway-based seafood company Mowi is also rising 3%.

Danish insurer Topdanmark's shares are up 4.6%, as well as Norwegian semiconductor company, up 3.2%, and Dutch electric grid equipment maker Alfen - up 3%.

Insurers are outperformers on a sector basis, up 0.6%, while healthcare names are the worst off, making the sector the biggest negative weight on the STOXX. AstraZeneca is the biggest drag on a weighted basis for the index and one reason why the FTSE 100 is down 0.43% today.

Investors are awaiting the UK's January business activity data due 0930 GMT.

IT'S ALL ABOUT THE WEATHER (0747 GMT)

It's been another quiet session in Asia with many markets still on holiday. Japan was open and the BOJ's dogged defence of Yield Curve Control seems to be working with 10-year yields holding around 0.39% and away from the 0.5% ceiling.

Notably, the BOJ's new 1 trillion yen ($7.7 billion) offer of five-year funds on Monday drew bids for three times as much, suggesting this could prove a useful method of injecting added liquidity into the market. Essentially banks could borrow at an average 0.145% fixed for five years to invest in JGBs - what could go wrong?

With spreads widening against the yen, the USD has gained 1.7% in the past two sessions and stands around 130.30, while the AUD is up over 3% as an old favourite of the carry trade.

The euro hasn't been able to regain its $1.0927 top but did find support at $1.0850. Bulls are hoping the flash S&P global surveys on Tuesday will confirm the EU economy is currently faring better than the United States, in a reversal of fortunes.

The EU manufacturing PMI is seen edging up to 48.5 in early January from 47.8, and services to 50.2 from 49.8, reflecting in part sharply lower gas prices and the relatively warm winter so far.

JPMorgan is forecasting NWE gas storage will be 56% full at the end of winter, nearly 30%-points higher than the five-year average and a drag on prices.

The U.S. manufacturing PMI is forecast to dip to 46.0 from 46.2, with services at 45.0 from 44.7. Ironically, the weather in the States in recent weeks has been a lot worse than in Europe, which was not how this story was supposed to pan out.

Elsewhere, U.S. stock futures have been becalmed in Asia after rallying overnight. Nasdaq futures gained 2% led by semiconductor and other tech stocks, with some suggesting the recent run of job layoffs in the sector represents a new focus on cutting costs and lifting profits.

Microsoft reports after the bell with the focus on how its cloud and enterprise units are doing, though its reported $10 billion investment in OpenAI is likely to get more column inches in the media. Others reporting include Johnson & Johnson, Verizon and Texas Instruments.

Key developments that could influence markets on Tuesday:

- ECB head Lagarde speaks, but a video message at a roundtable on "The euro as a guarantee of resilience" doesn't sound exactly market moving.

EUROPEAN STOCKS SET FOR MARGINAL GAINS (0734 GMT)

European futures are signalling marginal gains at the open, echoing a firmer tone on the U.S. market on Monday, where the S&P 500 closed 0.52% higher.

Eurostoxx 50 March futures are up 0.2%. European shares are steadily heading higher, even though the ECB is widely expected to deliver two consecutive 50bps in February and March, which has sent the euro surging.

But ECB policymakers have expressed diverging views, suggesting that the outlook beyond next week's meeting is not quite as clear.

German consumer sentiment is set to improve for a fourth consecutive month in February as energy prices fall, a GfK institute survey showed on Tuesday.

Over in Japan, manufacturing activity contracted for a third straight month in January.

Meanwhile, U.S. tech stocks have gained 5% in the last two trading sessions, lifted by an expectation of slower rate hikes by the Fed.

Microsoft will publish its fiscal year 2023 second-quarter financial results later today, which should offer more insight into the outlook for tech and growth stocks.

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.